Since January 1, the Department of Transportation extended its Drug Testing Panel adding four semi-synthetic opioids; oxycodone, hydromorphone, hydrocodone, and oxymorphone, which are usually taken as pain pills. Cocaine, amphetamines, marijuana and PCP will still be tested in the Department of Transportation’s drug test panel.
The objective of the DOT is to contribute solving the epidemic of opioid use in the U.S., a fact stated by the president Trump as a nationwide health problem. And the industry of transportation it is also vulnerable to this national trend of drug abuse.
DOT officials consider that expanding the range of opioids tested will help increase the safety on the road and also reduce opioid use. More information about DOT drug testing policies is available at https://www.transportation.gov/odapc.